Literature DB >> 31278965

LncRNA MIR503HG is downregulated in Han Chinese with colorectal cancer and inhibits cell migration and invasion mediated by TGF-β2.

Dongyu Chuo1, Fang Liu1, Yuze Chen1, Mingdi Yin2.   

Abstract

In this study we investigated the role of lncRNA MIR503HG in colorectal cancer (CRC). We found that MIR503HG was downregulated and TGF-β2 was upregulated in CRC included in this study. Low levels of MIR503HG were associated with poor survival of CRC patients within 5 years after admission. MIR503HG and TGF-β2 were inversely correlated in CRC tissues, and in CRC cells, MIR503HG overexpression was accompanied by TGF-β2 downregulation, while TGF-β2 overexpression did not affect MIR503HG. TGF-β2 overexpression mediated the increased migration and invasion rates of CRC cells. MIR503HG overexpression mediated the decreased migration and invasion rates of CRC cells. Moreover, TGF-β2 overexpression reduced the effects of MIR503HG overexpression. Therefore, MIR503HG overexpression inhibits CRC cell migration and invasion mediated by TGF-β2.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Survival; TGF-β2; lncRNA MIR503HG

Mesh:

Substances:

Year:  2019        PMID: 31278965     DOI: 10.1016/j.gene.2019.143960

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  LncRNA, a novel target biomolecule, is involved in the progression of colorectal cancer.

Authors:  Weihong Sun; Shaoshao Ren; Ran Li; Qingshan Zhang; Haiping Song
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

2.  ENST00000430471 Promotes Development and Metastasis of Colorectal Cancer by Regulating the Expression of YBX-1.

Authors:  Zhenghai Zhu; Xiaoxin Zhang; Ying Zhou; Jie Cheng; Zipeng Xu
Journal:  Cancer Manag Res       Date:  2020-08-11       Impact factor: 3.989

3.  MIR503HG Loss Promotes Endothelial-to-Mesenchymal Transition in Vascular Disease.

Authors:  Julie Rodor; João P Monteiro; Axelle Caudrillier; Jessica P Scanlon; Ana-Mishel Spiroski; Tatiana Dudnakova; Beatrice Pflüger-Müller; Alena Shmakova; Alex von Kriegsheim; Lin Deng; Richard S Taylor; John R Wilson-Kanamori; Shiau-Haln Chen; Kevin Stewart; Adrian Thomson; Tijana Mitić; John D McClure; Jean Iynikkel; Patrick W F Hadoke; Laura Denby; Angela C Bradshaw; Paola Caruso; Nicholas W Morrell; Jason C Kovacic; Igor Ulitsky; Neil C Henderson; Andrea Caporali; Matthias S Leisegang; Ralf P Brandes; Andrew H Baker
Journal:  Circ Res       Date:  2021-03-11       Impact factor: 17.367

4.  Identification of crucial noncoding RNAs and mRNAs in hypertrophic scars via RNA sequencing.

Authors:  Xiaodong Li; Zeliang He; Julei Zhang; Yan Han
Journal:  FEBS Open Bio       Date:  2021-05-12       Impact factor: 2.693

5.  lncRNA LUNAR1 accelerates colorectal cancer progression by targeting the miR‑495‑3p/MYCBP axis.

Authors:  Jiajie Qian; Alok Garg; Fuqiang Li; Qianyun Shen; Ke Xiao
Journal:  Int J Oncol       Date:  2020-09-25       Impact factor: 5.650

6.  lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis.

Authors:  Shou-Man Wang; Jian Pang; Ke-Jing Zhang; Zhi-Yang Zhou; Fei-Yu Chen
Journal:  Mol Ther Oncolytics       Date:  2021-03-17       Impact factor: 7.200

7.  The LncRNA MIR503HG/miR-224-5p/TUSC3 Signaling Cascade Suppresses Gastric Cancer Development via Modulating ATF6 Branch of Unfolded Protein Response.

Authors:  Han Lin; Jinge Wang; Tong Wang; Jiaming Wu; Peng Wang; Xiaoyan Huo; Jun Zhang; Huayang Pan; Yuying Fan
Journal:  Front Oncol       Date:  2021-07-26       Impact factor: 6.244

8.  Progress of Noncoding RNA Regulating the Growth and Development of Antler Tissue Research.

Authors:  Yipu Wang; Wei Hu
Journal:  Biomed Res Int       Date:  2022-07-19       Impact factor: 3.246

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.